Board of Directors

Meg Spencer, Chairman of the Board. Meg Spencer is CEO and President of Hamilton Biovet, Inc., a supplier of large and small animal breeding, diagnostic and therapeutic products. Previously, she served as Chief Strategic Advisor to the Corporation and HT Inc. Prior to that, she was Chief Executive Officer of HT Inc. from its founding in 1997 to September 2011 and Chief Executive Officer of the Corporation from October 2009 to September 2011. Ms. Spencer founded two previous companies, taking each from start-up to global market leadership in their respective sectors. Hamilton Equine Systems, Inc., a high tech veterinary products company, was successfully sold at an attractive return on investment for its investors. Hamilton-Thorne Research offered reproductive toxicology testing systems for the study of the effects of chemicals, pesticides and prescription drugs on human and animal reproduction.

Diarmaid H. Douglas-Hamilton, Director, Corporate Secretary, Chief Technology Officer and Senior Vice President of Research & Development of Hamilton Thorne - Mr. Douglas-Hamilton is a co-founder, Chief Technology Officer and Senior Vice-President Research & Development of Hamilton Thorne and a Director and Chief Technology Officer of Hamilton Thorne, Ltd. He was formerly Principal Scientist and Project Director at Avco Everett Laboratories, and Technical Director at Eaton Corp. He is a physicist with broad specialties in optics and lasers, holding multiple patents in assorted fields. Mr. Douglas-Hamilton has extensive experience in effectively managing large and small research and development projects. Mr. Douglas-Hamilton was formerly a director of Hamilton Thorne, Inc.

Dean Gendron, Director, Member of Compensation Committee and Audit Committee - Mr. Gendron is the founder, President and CEO of Redan Capital Incorporated, a company that provides M&A, corporate finance and investment banking advisory services to early stage and developed private and public companies. Previously, Mr. Gendron was the Chief Executive Officer of Blue Gold Canada Ltd., a supplier of nanotechnology products for water purification and the Chairman of the Board, President, Chief Executive Officer and founder of Calotto Capital Inc., a predecessor to the Corporation. Mr. Gendron provided key leadership in the financing and growth of Critical Outcome Technologies Inc., a drug discovery and development company, including its financing activities and concurrent reverse takeover of Aviator Petroleum Corp., a TSX Venture Exchange-listed capital pool company, and served as a director of Critical Outcome Technologies Inc. In addition, Mr. Gendron was the President and Chief Executive Officer of DDP Therapeutics, an early stage drug development company and a founder and is a Director of KCC Capital Corporation, a TSX Venture Exchange-listed capital pool company. He is currently a member of the TSX-V Ontario Advisory Committee and a member of the TSX-V National Advisory Committee.

Bruno Maruzzo, Director and Chair of Audit Committee - Mr. Bruno Maruzzo is President of TechnoVenture Inc., a technology consulting company. Mr. Maruzzo has worked with a variety of public and private high technology companies in the computer, medical instrumentation and biotechnology sectors, where he held positions in a range of areas including business development, corporate development, investor relations, engineering management and general management. He has also worked in the venture capital field, sourcing, assessing and making investments in early-stage technology-based companies in Canada and the US. Mr. Maruzzo is currently a director of Pinetree Capital Ltd., a TSX-listed company, and Critical Outcome Technologies Inc., Minati Capital, Drift Lake Resources, Cleanfield Alternative Energy, all TSX Venture Exchange-listed companies.

Robert J. Potter, Director and Chair of Compensation Committee - Mr. Potter is Senior Vice President and General Manager, Business Information and Analytics of Rocket Software.  Prior to that, he was co-founder and Chief Executive Officer of Expressor Software Corporation a company that was acquired by QlikTech International AB. After the acquisition, Mr. Potter served as Vice President of Business Development for the QlikTech‚Äôs Big Data Strategic Partners. Mr. Potter has served with Sigma Partners, a leading venture group in Boston, and was formerly President and CEO of Kalido Corporation, where he grew revenues from US$5.6M to US$18.5M in two and one half years; Executive Vice President of Iona Technologies where he engineered growth of the company into a US$180M global enterprise, and Senior Vice President of Worldwide Sales and Services at Object Design, Inc., where he grew sales from US$1M to US$38M and the Inc 500 award as the fastest growing company in the USA. Mr. Potter was formerly a director of Hamilton Thorne, Inc.

David Sable, Director - Dr. Sable is a Portfolio Manager of Special Situations Life Sciences Fund. Previously, Dr. Sable was Director of the Institute for Reproductive Medicine and Science at Saint Barnabas Medical Center in New Jersey. He is board certified in both obstetrics and gynecology and reproductive endocrinology, and has held academic positions at Harvard Medical School and the Columbia University Graduate School of Arts and Sciences. Dr. Sable is a graduate of the Wharton School and the University Of Pennsylvania School of Medicine. Dr. Sable also serves on the board of directors of RESOLVE: The National Infertility Society and on the advisory board of OvaScience

Daniel K. Thorne, Director and Member of Compensation Committee - Mr. Thorne is President of Star Lake Capital, Inc., a private venture capital firm that invests in technology companies, and its related fund, Star Lake Bioventures LLC. Mr. Thorne is also a Trustee of the Wildlife Conservation Society, a Trustee of the National Trust for Historic Preservation, and a member of the board of Environmental News Television, Inc. Mr. Thorne was formerly a director of Hamilton Thorne, Inc.

David Wolf, Director, Chief Executive Officer and President- Mr. Wolf is a senior level executive with over 20 years of success in solving complex business issues and building shareholder value in both public and private companies. Previously, David was a member of the founding management team of Elcom International, Inc. (NASDAQ), where he played a key role in growing the business to $800 million in revenues in four years and orchestrating Elcom's successful IPO. As President of Elcom Systems, David transformed an internal development organization into a full-fledged software development, marketing and services company that successfully implemented electronic commerce systems for companies around the world.  Prior to Elcom, David was Chief Operating Officer of JWP Information Services, a subsidiary of JWP Inc. (NYSE) where he built the operational infrastructure to support its growth from $250 million to $1.4 billion in sales , and President and COO of NEECO, Inc. (NASDAQ), a $250 million business IT distribution and services business purchased by JWP.